Renal Cell Carcinoma (RCC) Upon Disease Progression: Next Steps

Access Course

 

885328.jpg?interpolation=lanczos-none&resize=300:225Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

 

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

 

 

This activity is intended for hematology/oncology specialists, pulmonologists, and pathologists.

 

The goal of this activity is to build healthcare professionals’ confidence in strategies for the individualized treatment of the patient with renal cell carcinoma (RCC) and to ensure that best practices are applied across a variety of clinical presentations.

 

Approximate Time to Complete: 30 minutes

 

Credit Available: Dec. 15, 2017 - Dec. 15, 2018

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Choose the most appropriate regimen for a patient with metastatic RCC
  • Identify appropriate strategies to mitigate treatment-related adverse effects
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 1.00
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 1.00